MedPath

Tear Film Innovations, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

iLux Treatment for Meibomian Gland Dysfunction (MGD)

Not Applicable
Completed
Conditions
Evaporative Dry Eye
Interventions
Device: iLux 2020 System
First Posted Date
2017-02-16
Last Posted Date
2020-11-12
Lead Sponsor
Tear Film Innovations, Inc.
Target Recruit Count
30
Registration Number
NCT03055650
Locations
🇺🇸

TearFilm Investigative Site, San Diego, California, United States

Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction

Not Applicable
Completed
Conditions
Meibomian Gland Dysfunction
Interventions
Device: iLux 2020 System
Device: LipiFlow Pulsation System
First Posted Date
2017-02-16
Last Posted Date
2023-04-12
Lead Sponsor
Tear Film Innovations, Inc.
Target Recruit Count
142
Registration Number
NCT03055832
Locations
🇺🇸

TearFilm Investigative Site, Kansas City, Missouri, United States

Tear Film Innovations iLux Safety Study

Not Applicable
Completed
Conditions
Evaporative Dry Eye
Meibomian Gland Dysfunction
Interventions
Device: iLux 2020 System
First Posted Date
2017-02-16
Last Posted Date
2023-04-12
Lead Sponsor
Tear Film Innovations, Inc.
Target Recruit Count
15
Registration Number
NCT03055897
Locations
🇺🇸

TearFilm Innovations Investigative Site, Encinitas, California, United States

© Copyright 2025. All Rights Reserved by MedPath